Mira Chaurushiya, Ph.D. joined 5AM Ventures as an Associate in 2015 from Genentech, where she was a Postdoctoral Fellow in the Department of Physiological Chemistry studying mouse models of cancer and stem cells. Dr. Chaurushiya currently serves as an Observer on the Boards of Chrono Therapeutics, Precision Nanosystems and Startide Sciences. She is a Fellow of the Society of Kauffman Fellows. Prior to Genentech, Dr. Chaurushiya completed her Ph.D. work at the Salk Institute, where she studied Herpes Simplex Virus infections and epigenetics. Her work has been published in Science and PNAS, among others. Dr. Chaurushiya received a Ph.D. in Biological Sciences from the University of California, San Diego in conjunction with the Salk Institute for Biological Studies, where she was awarded the Martin Kamen Thesis Prize in Biochemistry. She received her B.A. in Biology from Carleton College. Dr. Chaurushiya is based in the San Francisco, CA office.
Copyright © 2017 5AM Venture Management LLC